Literature DB >> 11818705

Hepatocyte growth factor protects functional and histological disorders of HgCl(2)-induced acute renal failure mice.

Naoki Yamasaki1, Tomokazu Nagano, Ikue Mori-Kudo, Atsushi Tsuchida, Takao Kawamura, Hitoshi Seki, Mutsuo Taiji, Hiroshi Noguchi.   

Abstract

Hepatocyte growth factor (HGF) enhances proliferation of renal epithelial cells as well as hepatocytes. HGF accelerates recovery from acute renal failure (ARF) in animal models. However, pharmacological profiles of HGF including its action mechanism has not been studied in detail. An HgCl(2)-induced ARF mouse was used in this study to evaluate the efficacy of HGF. Single administrations of recombinant human HGF or vehicle were given to ARF mice 30 min after HgCl(2) injection. Renal function was monitored by measuring serum creatinine, blood urea nitrogen and creatinine clearance. In the ARF mice, there was a deterioration of renal function biochemical parameters and histological evidence of renal damage including acute tubular necrosis of proximal tubules. These were both significantly ameliorated by a single HGF administration. The effect of HGF was noticeable in the early phase of ARF (1 day after onset) when there was no histological evidence of increased labeling indexes in renal tubular epithelial cells. Western blot analysis of the c-Met/HGF receptor showed that tyrosine phosphorylation was enhanced immediately after HGF administration indicating direct activation of renal epithelial cells. HGF prevented increase of apoptotic nuclei with DNA fragmentation in renal epithelial cells which suggests cytoprotective activity of HGF on renal epithelial cells in the ARF mice. Copyright 2002 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11818705     DOI: 10.1159/000049042

Source DB:  PubMed          Journal:  Nephron        ISSN: 1660-8151            Impact factor:   2.847


  5 in total

1.  Diminished met signaling in podocytes contributes to the development of podocytopenia in transplant glomerulopathy.

Authors:  Putri A Agustian; Mario Schiffer; Wilfried Gwinner; Irini Schäfer; Katharina Theophile; Friedrich Modde; Clemens L Bockmeyer; Jana Traeder; Ulrich Lehmann; Anika Grosshennig; Hans H Kreipe; Verena Bröcker; Jan U Becker
Journal:  Am J Pathol       Date:  2011-05       Impact factor: 4.307

2.  Hepatocyte Growth Factor Mimetic ANG-3777 for Cardiac Surgery-Associated Acute Kidney Injury.

Authors:  Sabry Ayad; John F Neylan; Tracy J Mayne; Deborah Gouveia; Madhav Swaminathan
Journal:  Kidney Int Rep       Date:  2020-09-25

3.  c-Met tyrosine kinase receptor expression and function in human and canine osteosarcoma cells.

Authors:  E Gregory MacEwen; Jon Kutzke; Jennifer Carew; Josep Pastor; Julie A Schmidt; Rachel Tsan; Douglas H Thamm; Robert Radinsky
Journal:  Clin Exp Metastasis       Date:  2003       Impact factor: 5.150

Review 4.  HGF-Met Pathway in Regeneration and Drug Discovery.

Authors:  Kunio Matsumoto; Hiroshi Funakoshi; Hisaaki Takahashi; Katsuya Sakai
Journal:  Biomedicines       Date:  2014-10-31

5.  Combination of biomarker with clinical risk factors for prediction of severe acute kidney injury in critically ill patients.

Authors:  Lan Jia; Xiaohua Sheng; Anna Zamperetti; Yun Xie; Valentina Corradi; Shikha Chandel; Massimo De Cal; Diego Pomarè Montin; Carlotta Caprara; Claudio Ronco
Journal:  BMC Nephrol       Date:  2020-12-10       Impact factor: 2.388

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.